End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.92 CNY | +5.02% | +15.48% | +29.24% |
Apr. 19 | Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 18 | Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules | MT |
Sales 2024 * | 3.88B 536M | Sales 2025 * | 5.1B 706M | Capitalization | 33.02B 4.57B |
---|---|---|---|---|---|
Net income 2024 * | 552M 76.33M | Net income 2025 * | 633M 87.53M | EV / Sales 2024 * | 8.52 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.47 x |
P/E ratio 2024 * |
59.8
x | P/E ratio 2025 * |
53
x | Employees | 5,448 |
Yield 2024 * |
0.4% | Yield 2025 * |
0.5% | Free-Float | 20.41% |
1 day | +5.02% | ||
1 week | +15.48% | ||
Current month | +10.28% | ||
1 month | +10.65% | ||
3 months | +31.86% | ||
6 months | +25.45% | ||
Current year | +29.24% |
Managers | Title | Age | Since |
---|---|---|---|
Xiu Lian Fan
CEO | Chief Executive Officer | 61 | 06-12-31 |
Peng Duan
DFI | Director of Finance/CFO | 49 | 16-10-20 |
Jun Min Wang
CHM | Chairman | 56 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Min Wang
CHM | Chairman | 56 | 06-12-31 |
Wei Zheng
BRD | Director/Board Member | 54 | 06-12-31 |
Xiu Lian Fan
CEO | Chief Executive Officer | 61 | 06-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-28 | 29.92 | +5.02% | 5 297 955 |
24-04-26 | 28.49 | +1.03% | 5,014,870 |
24-04-25 | 28.2 | +3.37% | 5,018,471 |
24-04-24 | 27.28 | +1.41% | 3,321,500 |
24-04-23 | 26.9 | +1.89% | 4,695,500 |
End-of-day quote Shenzhen S.E., April 28, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.24% | 4.34B | |
+25.99% | 661B | |
+26.74% | 566B | |
-6.76% | 352B | |
+19.31% | 332B | |
+3.51% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.27% | 145B |
- Stock Market
- Equities
- 002653 Stock